Defining the potential of class-IIa histone deacetylases as a therapeutic target for Parkinson’s disease

Files in this item

This item appears in the following Collection(s)

© 2021, Martina Mazzocchi. Except where otherwise noted, this item's license is described as © 2021, Martina Mazzocchi.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement